Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises joint arrangers in connection with Sehlhall Fastigheter's issuance of sustainable bonds and refinancing
Mandate

Vinge advises joint arrangers in connection with Sehlhall Fastigheter's issuance of sustainable bonds and refinancing

March 26, 2024 Banking and Finance

Vinge has advised the joint arrangers in connection with Sehlhall Fastigheter AB's (the "Company") issue of SEK 200 million senior secured sustainable bonds and in connection with the parallel early redemption of existing bonds issued by its subsidiary, Sehlhall Holding AB (the "Subsidiary").

The new bonds carry a floating interest rate of STIBOR 3M + 8,00% and are due in March 2027. The Company intends to apply for admission to trading of the new bonds on Nasdaq Stockholm's list for sustainable bonds.

 

The new bond issuance was subscribed through a repurchase of outstanding bonds issued in the Subsidiary and against cash consideration. The Company’s bond repurchase was effectuated partly by existing bondholders in the Subsidiary paying for the new bonds with their existing bonds and partly by way of issuing subordinated promissory notes.

 

Skandinaviska Enskilda Banken AB (publ) and Swedbank AB (publ) acted as Joint Bookrunners. Swedbank AB (publ) also acted as Sole Structuring Advisor for the Company's sustainability framework.

Vinge's team consisted of Albert Wållgren, Arvid Weimers, Lionardo Ojeda, Felix Möller, August Ahlin and Rebecka Margolin.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025